Concepedia

Marjolein van der Poel

MV

Statistics

Publications

44

Citations

1.7K

H-Index

22

Active since

2001

Affiliations

Maastricht University(Current)

Isala

Medical College of Wisconsin

The University of Texas MD Anderson Cancer Center

University Hospital of Bern

Marjolein van der Poel is an author at Maastricht University specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

2001–2024

44

Publications

44

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

Catherine Thiéblemont, Tycel Phillips, Hervé Ghesquières et al. · Journal of Clinical Oncology · 2022 · 484 citations · Full text

Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial

Catherine Thiéblemont, Yasmin Karimi, Hervé Ghesquières et al. · Leukemia · 2024 · 87 citations · Full text

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Matthew J. Wieduwilt, Leland Metheny, Mei‐Jie Zhang et al. · Blood Advances · 2021 · 74 citations · Full text

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors

Guru Subramanian Guru Murthy, Soyoung Kim, Zhen‐Huan Hu et al. · JAMA Oncology · 2022 · 73 citations · Full text

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Mirian Brink, Frederik O. Meeuwes, Marjolein van der Poel et al. · Blood · 2022 · 66 citations · Full text

, , +27

1–5 of 44